Literature DB >> 11230505

Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.

L Balducci, G H Lyman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11230505     DOI： 10.1200/JCO.2001.19.5.1583

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

Review 1.  Pharmacology of anticancer drugs in the elderly population.

Authors:  Hans Wildiers; Martin S Highley; Ernst A de Bruijn; Allan T van Oosterom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Drug-induced myelosuppression : diagnosis and management.

Authors:  Peter J Carey
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Geriatric oncology: an overview of progresses and challenges.

Authors:  Martine Extermann
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

Review 4.  Treatment of breast cancer with chemotherapy in combination with filgrastim: approaches to improving therapeutic outcome.

Authors:  Giuseppe Frasci
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Filgrastim in patients with neutropenia: potential effects on quality of life.

Authors:  Gary H Lyman; Nicole M Kuderer
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.

Authors:  Shrujal S Baxi; Caitriona O'Neill; Eric J Sherman; Coral L Atoria; Nancy Y Lee; David G Pfister; Elena B Elkin
Journal:  Head Neck       Date:  2015-06-26       Impact factor: 3.147

Review 7.  The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.

Authors:  Ronald Maggiore; Zachary S Zumsteg; Karlynn BrintzenhofeSzoc; Kelly M Trevino; Ajeet Gajra; Beatriz Korc-Grodzicki; Joel B Epstein; Stewart M Bond; Ira Parker; Julie A Kish; Barbara A Murphy; Noam A VanderWalde
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-07-15       Impact factor: 7.038

8.  Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Authors:  Arti Hurria; Kelly Brogan; Katherine S Panageas; Ann Jakubowski; Marjorie Zauderer; Carol Pearce; Larry Norton; Jane Howard; Clifford Hudis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 9.  Management issues for elderly patients with breast cancer.

Authors:  Martine Extermann
Journal:  Curr Treat Options Oncol       Date:  2004-04

10.  Docetaxel as single-agent treatment in elderly patients with advanced breast cancer.

Authors:  I Lorenzo; M Constenla; P Palacios; F R García-Arroyo; I Fernández; B Campos; L Salgado; N Carrete
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.